Merz Aesthetics has unveiled Ultherapy PRIME, a noninvasive, FDA-cleared treatment designed to provide personalized and long-lasting lifting results in a single session, with no recovery time required.

This platform builds on the success of the original Ultherapy®, known for its substantial clinical evidence, established mechanism of action, and high levels of patient satisfaction.

Ultherapy PRIME integrates advanced ultrasound technology with enhanced real-time imaging to redefine noninvasive lifting.

These innovations ensure natural-looking outcomes while promoting overall skin health. The platform features a modern design and an upgraded operating system that allows for treatments that are 20% faster, with improved ergonomics and more efficient workflows for healthcare professionals.

Its 35% larger screen and enhanced image refresh rate deliver clearer, brighter visuals, enhancing the overall user experience.

The unique technology of Ultherapy PRIME employs real-time visualization to effectively target specific tissue layers at varying depths, delivering precise energy where it is most needed.

This capability enables tailored lifting results that can last up to a year or longer, making it suitable for a diverse range of patients.

With over three million Ultherapy treatments conducted globally, Ultherapy PRIME safely lifts and rejuvenates various areas of the face and neck.

Supported by a strong clinical foundation, with a 95% satisfaction rate reported after one year and referenced in numerous publications and studies, Ultherapy PRIME stands out as a reliable option for effective lifting.

This new platform represents a significant advancement in noninvasive aesthetic treatments, enhancing the ability to achieve a youthful and revitalized appearance in just one session, without the need for downtime.

 

 

Source: businesswire.com

Report Abuse